Bladder and Kidney Tumor Center
Kidney and bladder tumors are among the most common tumors of the genitourinary tract in addition to prostate cancer. Particularly in advanced tumors, a close cooperation of different disciplines is of great importance in order to enable our patients optimal clarification, therapy and follow-up. The interdisciplinary Uro-Oncological Tumor Board and the unique Interdisciplinary Uro-Oncology Consultation, in which our patients are treated together with urological, oncological and, if necessary, radio-oncological care, offers the best prerequisites for optimal, individually tailored care for our patients.
The therapy of renal cell carcinoma and urothelial carcinoma of the bladder is directed v. after the tumor stage at the time of diagnosis.
Kidney tumors are often discovered by chance during the evaluation of non-specific symptoms in the abdomen. Kidney tumors are usually treated by surgery (kidney-preserving partial resection with the Da Vinci surgical robot, renal total removal). Small kidney tumors may also be monitored regularly or treated by radiofrequency ablation or cryotherapy after the level of aggressiveness has been determined by biopsy. If there are already offshoots, after interdisciplinary discussion in our Interdisciplinary Uro-Oncological Tumor Board either an operative removal of the offshoot or, if this is not possible, a system therapy (so-called "targeted therapy" or immunotherapy) is performed.
Bladder tumors are usually detected by blood detection in the urine or micturition symptoms. Primarily, the tumor is always treated by a scraping of the tumor by an endoscopic operation through the urethra (so-called transurethral resection (TUR)). If the tumor does not grow into the muscles of the bladder, it can be checked with regular bladder reflexology, if necessary in combination with local immunotherapy (so-called BCG instillation therapy). If a muscle-invasive tumor is present, an interdisciplinary evaluation is always carried out in our Uro-Oncological Tumor Board. I.d.R. Primarily, chemotherapy should be used followed by removal of the urinary bladder and pelvic lymph nodes with urinary drainage via an artificial outlet or a so-called neobladder built up from the intestine. In favorable cases, a tumor growing into the musculature can also be treated with a bladder by transurethral resection followed by chemoradiation. If there are already offshoots, chemotherapy or immunotherapy will be carried out after an interdisciplinary discussion in the Uro-Oncological Tumor Board.
The oncology colleagues at the University Hospital Zurich provide oncology patients with an interdisciplinary approach. In the context of tumor boards, the treatment of patients is discussed across disciplines and determined together.
Referring physicians may attend the conference upon prior notification and present their patients to the conference or send the patient records for evaluation to receive a treatment recommendation.
To introduce patients to a tumor conference, please contact the respective contact person.
Research & trials
As part of the bladder and kidney tumor center, various studies on renal cell carcinoma and bladder cancer
are being carried out.
University Hospital Zurich
Department of Urology
Frauenklinikstr. 10, NORD1
Tel. +41 44 255 54 40
Fax +41 44 255 45 55
Für die Anzeige der korrekten Personen müssen Sie in den Webpart-Einstellungen die gewünschte Gruppe auswählen.